| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 |
| Total Revenue | 239 | 225 | 164 | 222 |
| Cost of Revenue |
-
|
-
|
-
| (10) |
|
| Gross Profit | 239 | 225 | 164 | 232 |
|
| Operating Expenses |
| Research Development |
-
| (5) | 5 | 6 |
| Selling General and Administrative | 351 | 566 | 273 | 673 |
| Non Recurring |
-
|
-
|
-
|
-
|
| Others |
-
|
-
|
-
|
-
|
| |
| Total Operating Expenses |
-
|
-
|
-
|
-
|
|
|
| Operating Income or Loss | (112) | (335) | (114) | (447) |
|
| Income from Continuing Operations |
| Total Other Income/Expenses Net | (23) | (85) |
-
| 40 |
| Earnings Before Interest And Taxes | (136) | (421) | (114) | (407) |
| Interest Expense | 10 | 0 |
-
|
-
|
| Income Before Tax | (146) | (421) | (114) | (407) |
| Income Tax Expense |
-
|
-
|
-
|
-
|
| Minority Interest |
-
|
-
|
-
|
-
|
| |
| Net Income From Continuing Ops | (146) | (421) | (114) | (407) |
|
| Non-recurring Events |
| Discontinued Operations |
-
|
-
|
-
|
-
|
| Extraordinary Items |
-
|
-
|
-
|
-
|
| Effect Of Accounting Changes |
-
|
-
|
-
|
-
|
| Other Items |
-
|
-
|
-
|
-
|
|
|
| Net Income | (146) | (421) | (114) | (407) |
| Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
|
|
| Net Income Applicable To Common Shares | ($146) | ($421) | ($114) | ($407) |
0.49% Nasdaq 
Income Statement
